Syndax Pharmaceuticals
SNDX
SNDX
84 hedge funds and large institutions have $106M invested in Syndax Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less call options, than puts
Call options by funds: $387K | Put options by funds: $448K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
57% less capital invested
Capital invested by funds: $244M → $106M (-$138M)
Holders
84
Holding in Top 10
1
Calls
$387K
Puts
$448K
Top Buyers
| 1 | +$2.77M | |
| 2 | +$1.39M | |
| 3 | +$1.26M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.13M |
| 5 |
6CM
683 Capital Management
New York
|
+$644K |
Top Sellers
| 1 | -$14M | |
| 2 | -$4.27M | |
| 3 | -$4.25M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.17M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$1.94M |